EuropaBio is pleased to host its third Summit focused on biotechnology & biomanufacturing.
Biotechnology is a critical technology for Europe. Delivery of innovation into market drives competitiveness, security, supply chain resilience plus societal and environmental goals. Europe must be ambitious and globally aware, with a focus on securing its biotechnology capability within fast changing global geopolitics.
The current Commission has a significant opportunity to set and deliver on the ambition needed. Legislation such as the Biotech Act, plus the frameworks that we create for sectors including health, agri-food and manufacturing.
The half day Summit brings together EuropaBio Members and stakeholders to understand the ambition needed for legislation, how the EU and its Member States can deliver and recognition of global positioning needed.
It is supported by biotech product displays and EU projects, plus evening networking reception. It will be followed by a Summit Statement and public webinar hosted in November.
This event will be accessible by invitation only, for more information contact us at: communications@europabio.org and c.skentelbery@europabio.org
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.